Literature DB >> 12875970

Identification of genes up-regulated in urothelial tumors: the 67-kd laminin receptor and tumor-associated trypsin inhibitor.

Christine P Diggle1, Sheena Cruickshank, Jonathon D Olsburgh, Stephanie Pellegrin, Barbara Smith, Rosamonde E Banks, Peter J Selby, Margaret A Knowles, Jennifer Southgate, Patricia Harnden.   

Abstract

Studies investigating changes in gene expression in urothelial carcinoma have generally compared tumors of different stages and grades but comparisons between low-grade, noninvasive tumors and normal urothelium are needed to identify genes involved in early tumor development. We isolated the urothelium from a low-grade tumor and corresponding normal mucosa by laser capture microdissection on frozen sections. The RNA extracted was amplified to generate suppressive subtractive cDNA libraries. Random sequencing of cDNA clones identified approximately 100 unique species. Of these 83% were known genes, 15% had homology to genes with an unknown function in humans, and 2% did not show homology to any published gene sequence. Two of the known genes, the 67-kd laminin receptor (67LR) and tumor-associated trypsin inhibitor (TATI), had previously been associated with metastatic progression in many tumor types, although 67LR has not been investigated in urothelial tumors. Immunolabeling of the original tissue with antibodies against these two genes confirmed overexpression, validating our strategy: 67LR was not expressed in the normal urothelium but was present in the tumor, whereas TATI expression was confined to umbrella cells in the normal urothelium, but extended to all cell layers in the tumor. We investigated both markers further in a separate series of tumors of different stages and grades. TATI was more consistently overexpressed than 67LR in all tumor grades and stages. Levels of secreted TATI were significantly higher in urine samples from patients with tumors compared to controls. Our strategy, combining laser capture microdissection and cDNA library construction, has identified genes that may be involved in the early phases of urothelial tumor development rather than with disease progression, highlighting the importance of comparing tumor with normal rather than just tumors of different stages and grades.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875970      PMCID: PMC1868207          DOI: 10.1016/S0002-9440(10)63678-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

Review 1.  Biomarkers for the detection of bladder cancer.

Authors:  J S Ross; M B Cohen
Journal:  Adv Anat Pathol       Date:  2001-01       Impact factor: 3.875

2.  Usefulness of the BTA STAT Test for the diagnosis of bladder cancer.

Authors:  J L Gutiérrez Baños; M del Henar Rebollo Rodrigo; F M Antolín Juárez; B M García
Journal:  Urology       Date:  2001-04       Impact factor: 2.649

3.  Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium.

Authors:  B A Smith; W J Kennedy; P Harnden; P J Selby; L K Trejdosiewicz; J Southgate
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

Review 4.  Laser capture microscopy.

Authors:  S Curran; J A McKay; H L McLeod; G I Murray
Journal:  Mol Pathol       Date:  2000-04

5.  Alterations of gene expression during colorectal carcinogenesis revealed by cDNA microarrays after laser-capture microdissection of tumor tissues and normal epithelia.

Authors:  O Kitahara; Y Furukawa; T Tanaka; C Kihara; K Ono; R Yanagawa; M E Nita; T Takagi; Y Nakamura; T Tsunoda
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

Review 6.  Molecular profiling of tissue samples using laser capture microdissection.

Authors:  C J Best; M R Emmert-Buck
Journal:  Expert Rev Mol Diagn       Date:  2001-05       Impact factor: 5.225

7.  Identification of a novel function for 67-kDa laminin receptor: increase in laminin degradation rate and release of motility fragments.

Authors:  Elena Ardini; Barbara Sporchia; Loredano Pollegioni; Michele Modugno; Cristina Ghirelli; Fabio Castiglioni; Elda Tagliabue; Sylvie Ménard
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

8.  A novel member of the glycosyltransferase family, beta 3 Gn-T2, highly downregulated in invasive human bladder transitional cell carcinomas.

Authors:  I Gromova; P Gromov; J E Celis
Journal:  Mol Carcinog       Date:  2001-10       Impact factor: 4.784

9.  Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays.

Authors:  V Luzzi; V Holtschlag; M A Watson
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

10.  bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer.

Authors:  Irina Gromova; Pavel Gromov; Julio E Celis
Journal:  Int J Cancer       Date:  2002-04-01       Impact factor: 7.396

View more
  2 in total

Review 1.  Urothelial carcinoma: stem cells on the edge.

Authors:  William D Brandt; William Matsui; Jonathan E Rosenberg; Xiaobing He; Shizhang Ling; Edward M Schaeffer; David M Berman
Journal:  Cancer Metastasis Rev       Date:  2009-12       Impact factor: 9.264

2.  Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma.

Authors:  Xiaobing He; Luigi Marchionni; Donna E Hansel; Wayne Yu; Akshay Sood; Jie Yang; Giovanni Parmigiani; William Matsui; David M Berman
Journal:  Stem Cells       Date:  2009-07       Impact factor: 6.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.